ArticleCell reports. Medicine2021

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope.

Swetha Raman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.